An Act relative to prescription drug price transparency

This bill requires Massachusetts' MassHealth program and large health insurers to annually publish lists of prescription drugs that have seen significant price increases, specifically those with costs rising by 50% over five years or 15% in the last year. The Attorney General will then select up to 15 of the most expensive drugs from these lists and mandate that manufacturers provide detailed documentation justifying the price hikes. Additionally, the bill establishes a regulatory framework with penalties for non-compliance and requires the Attorney General to report findings to the legislature each December.